GLP-1s Hit the Budget Wall

Editorial

Active GLP-1 use is finally climbing and natural-first resistance is receding, just as affordability becomes the binding constraint. Consumers accept the drug in principle and describe it as a drug for rich people, in the worst household budget climate the tracker has recorded.

Scope

Health + Affordability · Waves 1–7

Published

At launch

A proposal from the catalog, built on commission across the live programs; it publishes as its own cut.